IGF1 and cancer: In IGF1, cancer cells across all patients predominantly used the second exon of the gene as their transcription start site (secreted isoform, Class II), whereas non-cancerous cells primarily used the first exon (endogenous isoform, Class I)58 (Fig. 4d).